Role of TMPRSS2-ERG Gene Fusion in Negative Regulation of PSMA Expression
2011
Role of TMPRSS2-ERG Gene Fusion in Negative Regulation of PSMA Expression
publication
Evidence: moderate
Author Information
Author(s): Yin Lihong, Rao Pravin, Elson Paul, Wang Jianghua, Ittmann Michael, Heston Warren D. W.
Primary Institution: Cleveland Clinic
Hypothesis
PSMA expression could be regulated by the TMPRSS2-ERG fusion.
Conclusion
TMPRSS2-ERG fusions suppress PSMA expression in VCaP prostate cancer cells.
Supporting Evidence
- TMPRSS2-ERG fusion is the most common known gene rearrangement in prostate carcinoma.
- PSMA expression is negatively regulated by androgen stimulation.
- Knocking down ERG enhances PSMA expression in VCaP cells.
- Overexpressing TMPRSS2-ERG fusions in LNCaP cells downregulated PSMA.
Takeaway
This study found that a specific gene fusion in prostate cancer can lower the levels of a protein that is important for cancer treatment.
Methodology
The study used prostate cancer cell lines to analyze the effects of TMPRSS2-ERG fusion on PSMA expression through various treatments and assays.
Limitations
The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website